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OBJECTIVES We studied the effect of drug-eluting stent implantation for chronic total coronary occlusion
(CTO) on left ventricular volumes and function and assessed the predictive value of magnetic
resonance imaging (MRI) performed before revascularization.
BACKGROUND The effect of recanalization of CTO on long-term left ventricular function and the value of
myocardial viability assessment with MRI is incompletely understood.
METHODS Twenty-seven patients underwent contrast-enhanced MRI before and five months after
successful drug-eluting stent implantation for CTO. A CTO was defined as a complete
occlusion of a major epicardial coronary artery existing for at least six weeks (mean, 7  5
months). Myocardial wall thickening and left ventricular volumes were quantified on
cine-images, and the transmural extent of infarction (TEI) was scored on delayed-
enhancement images.
RESULTS A significant decrease in mean end-systolic volume index (34 13 ml/m2 to 31 13 ml/m2;
p  0.02) and mean end-diastolic volume index (84  15 ml/m2 to 79  15 ml/m2; p 
0.002) was observed, whereas the mean ejection fraction did not change significantly (61 
9% to 62  11%; p  0.54). The extent of the left ventricle that was dysfunctional but viable
before revascularization was related to improvement in end-systolic volume index (R  0.46;
p  0.01) and ejection fraction (R  0.49; p  0.01) but not to the end-diastolic volume
index (R  0.10; p  0.53). Segmental wall thickening improved significantly in segments
with 25% TEI (21  15% to 35  25%; p  0.001), tended to improve in segments with
25% to 75% TEI (18  22% to 27  22%; p  0.10), whereas segments with 75% TEI
did not improve (4  14% to 9  14%; p  0.54).
CONCLUSIONS Drug-eluting stent implantation for a CTO has a beneficial effect on left ventricular volumes
and function that can be predicted by performing MRI before revascularization. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.042Cardiol 2006;47:721–5) © 2006 by the American College of Cardiology Foundation
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ihronic total coronary occlusions (CTO) are observed in
5% to 50% of patients with significant coronary disease
ndergoing diagnostic angiography (1,2). Percutaneous cor-
nary intervention (PCI) for CTO is increasingly used as
reatment strategy and accounts for 10% to 15% of all
ngioplasties. New catheter-based techniques have led to
igher success rates of PCI (3), and drug-eluting stents
ignificantly reduce the incidence of restenosis and re-
cclusion (4). However, the effect of PCI on myocardial
ontractility and left ventricular volumes of the individual
atient with CTO is incompletely understood. Previous
tudies used left ventricular angiography to study left ven-
ricular function and volumes after balloon angioplasty or
are-metal stents for CTO, but results have been equivocal
5–7). These equivocal results may partly be caused by the
ather crude measurements offered by left ventricular an-
iography in conjunction with the high restenosis and
eocclusion rate after balloon angioplasty or bare-metal stent
mplantation. The use of contrast-enhanced magnetic res-
From the *Department of Cardiology, Thoraxcenter, and the †Department of
adiology, Erasmus Medical Center, Rotterdam, the Netherlands.l
Manuscript received June 13, 2005; revised manuscript received October 14, 2005,
ccepted October 17, 2005.nance imaging (ce-MRI) permits refined assessment of
yocardial contractility, left ventricular volumes, and the
ransmural extent of infarction (TEI) (8). We used ce-MRI
o study the effect of drug-eluting stent implantation for
TO on left ventricular volumes and function and to
valuate the diagnostic value of ce-MRI to predict improve-
ent in regional and global left ventricular function.
ETHODS
atient population. Patients scheduled for percutaneous
evascularization of a CTO of a native coronary artery and
ithout contraindications for MRI were prospectively se-
ected for enrollment in this study. Of 50 selected patients,
patients refused to participate, 47 patients underwent
RI at 16  16 days before PCI, and 27 patients
nderwent follow-up MRI at 5  1 months after PCI.
wenty patients did not undergo follow-up MRI; in 13
atients, PCI was not successful, 1 patient gained too much
eight to fit into the scanner, 1 patient had a defibrillator
mplanted, and 5 patients refused re-investigation. All
rocedures were performed by operators highly experienced
n the treatment of CTO, with the interventional strategy
eft to the discretion of the operator. All participants gave
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Myocardial Viability in Chronic Total Occlusions February 21, 2006:721–5ritten informed consent to the study protocol, which was
pproved by the medical ethics committee of the Erasmus
edical Center, Rotterdam. More patient characteristics
re listed in Table 1.
RI protocol. A 1.5-T MRI scanner with a dedicated
our-element phased-array receiver coil was used for imag-
ng (Signa CV/i, GE Medical Systems, Milwaukee, Wis-
onsin). Cine-MRI was performed at baseline and follow-up
ith a steady-state free-precession technique. Sequence details
ave been published (9). To cover the entire left ventricle,
to 12 consecutive slices of 8 mm in the short-axis view
ere planned on the four chambers (gap of 2 mm).
elayed enhancement imaging was performed at the base-
ine scan 10 to 20 min after administration of gadolinium-
iethyltriaminepentaacetic acid (0.1 mmol/kg intravenously,
agnevist, Schering, Germany). A two-dimensional T1-
eighted inversion recovery gradient-echo sequence was
sed as described previously (9). The inversion time was
djusted per patient to null the signal of remote myocar-
ium. Slice locations were copied from the locations of the
ine-images.
efinitions and data analysis. All conventional angio-
rams before revascularization were evaluated by two expe-
ienced observers (Drs. Baks and van Geuns). Collateral
unction was scored on a four-point scale (10). The CTO
as defined as a complete occlusion of a major coronary
Abbreviations and Acronyms
ce-MRI  contrast-enhanced magnetic resonance
imaging
CTO  chronic total coronary occlusion
PCI  percutaneous coronary intervention
SWT  segmental wall thickening
TEI  transmural extent of infarction
able 1. Baseline Patient Characteristics (n  27)
ge (yrs) 64  10
en 22 (81)
moking 9 (33)
iabetic mellitus 5 (19)
ypertension 6 (22)
ypercholesterolemia 5 (19)
amily history 12 (44)
istory of myocardial infarction 14 (52)
elayed enhancement before PCI 17 (63)
uration of procedure (min) 143  62
uration of occlusion (months) 7  5
ollateral filling (grade) 2 to 3
ime to follow-up (months) 5  1
aseline ejection fraction (%) 61  9
CE inhibitor 8 (30)
eta-blocker 22 (81)
lopidogrel (after PCI) 27 (100)
tatin 26 (96)
SA 27 (100)
alues are presented as n (%) or mean  standard deviation.2
ACE  angiotensin-converting enzyme; ASA  acetylsalicylic acid; PCI 
ercutaneous coronary intervention.rtery existing for at least six weeks as obtained from either
he date from the previous angiogram or the clinical history
f prolonged anginal chest pain or myocardial infarction.
eft ventricular volumes and mass were quantified using a
edicated software package (Mass, Medis, the Nether-
ands). Papillary muscles were considered as part of the left
entricular volume. Regional analysis per patient was as-
essed using a 16-segment model excluding the apex (11).
egmental wall thickening (SWT) was calculated by (end-
ystolic  end-diastolic wall thickness)/end-diastolic wall
hickness  100%. Myocardial segments were considered
ysfunctional if SWT was 45% or less (12). To study the
ffect of revascularization on SWT, segments in the perfu-
ion territory of a CTO (defined on conventional angio-
ram) were analyzed for wall thickening at baseline and at
ve months.
Two investigators (Drs. Baks and van Geuns), blinded for
he clinical data, analyzed delayed enhancement images for
he TEI, and the decision was made on the basis of
onsensus. The TEI was calculated by dividing the hyper-
nhanced area by the total area in 16 segments per patient
s: 1  0% (TEI), 2  1% to 25%, 3  26% to 50%, 4 
1% to 75%, 5 76% to 100%. A myocardial segment with
0% to 25% TEI was considered viable (13). The percent-
ge of dysfunctional but viable myocardium per patient was
alculated by dividing the sum of all dysfunctional but viable
egments by the total amount of segments.
tatistical analysis. Data are presented as mean  stan-
ard deviation. Two-way analysis of variance with repeated
easures over time followed by Bonferroni correction (four
roups) was used to compare changes in SWT in viable
egments (25% TEI), possible viable segments (26% to
5% TEI), non-viable segments (75% TEI), and remote
egments between baseline and follow-up and to evaluate
ifferences in SWT at baseline and at follow-up. The
hange in left ventricular volume indexes was tested with
aired Student t tests. The relationship between the viability
core per patient and the change in left ventricular volumes
as analyzed with univariate linear regression analysis. All
ests were performed two-sided, and significance was ac-
epted at a p value of  0.05.
ESULTS
atient population. The CTO was located in the left
nterior descending coronary artery in 14 patients, in the
ight coronary artery in 10 patients, and in the circumflex
oronary artery in 3 patients. The mean duration of occlu-
ion was 7  5 months. The overall mean procedural time
as approximately 143  62 min. A total of 432 segments
ere available for analysis, and no segments had to be
xcluded because of image quality.
eft ventricular function and volumes. Mean end-
ystolic volume index decreased significantly from 34  13
l/m2 to 31  13 ml/m2 (p  0.02; 66  29 ml to 60 8 ml, p  0.02), and mean end-diastolic volume index
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February 21, 2006:721–5 Myocardial Viability in Chronic Total Occlusionsecreased significantly from 84  15 ml/m2 to 79  15
l/m2 (p  0.002; 162  38 ml to 153  36 ml, p 
.002). Overall mean ejection fraction remained unchanged
rom 61  9% to 62  11% (p  0.54) (Fig. 1). The extent
f the left ventricle that was dysfunctional but viable before
evascularization was related to improvement in end-systolic
olume index (R 0.46; p 0.01) and ejection fraction (R
.49; p  0.01) but not to the end-diastolic volume index
R  0.10; p  0.53) (Fig. 2).
In dysfunctional but viable segments (25% TEI), mean
WT improved significantly from 21  15% to 35  25%
p  0.001), whereas mean SWT tended to improve from
8  22% to 27  22% (p  0.10) in segments with 25%
o 75% TEI and did not improve (4  14% to 9  14%;
 0.54) in segments with 75% TEI (Fig. 3). Improve-
ent of more than 10% in absolute SWT was observed in
6% of dysfunctional segments (16 of 21) with TEI 0%, in
7% (4 of 6) with TEI 1% to 25%, 35% (6 of 17) with TEI
6% to 50%, 35% (5 of 14) with TEI 51% to 75%, and 0%
0 of 4) with TEI 75%. The sensitivity, specificity, and
ositive and negative predictive values of MRI for predict-
ng segmental improvement were 65% (20 of 31), 77% (24
igure 1. The change in left ventricular volume indexes between baseline an
he mean ejection fraction remained unchanged, but end-systolic and endigure 2. Improvement in end-systolic volume index (ESVI) and ejection fracti
efore revascularization. No relationship was found for end-diastolic volume inf 31), 74% (20 of 27), and 69% (24 of 35), respectively,
sing 25% TEI as the threshold for viability. Left ven-
ricular mass index did not change significantly from 64 
3 g/m2 to 63  11 g/m2 (p  0.25; 127  27 g to 122 
2 g, p  0.26).
ISCUSSION
e showed the beneficial effect of successful drug-eluting
tent implantation for CTO on end-systolic and end-
iastolic volumes and SWT. Furthermore, we showed that
he extent of dysfunctional but viable myocardium before
evascularization was related to improvement in end-systolic
olume, ejection fraction, and SWT.
Previous studies investigated the effect of successful PCI
or CTO on left ventricular function (5,14–18). Overall, the
verage of left ventricular improvement is not overwhelming
nd is likely to escape detection by crude measurements of
lobal left ventricular ejection fraction, and seems to be
imited to fairly recent occlusions. In the current study, we
sed up-to-date methodology to study a well-defined group
f patients with a duration of occlusion of more than six
e months of follow-up measured with magnetic resonance imaging (MRI).
tolic volume index decreased significantly.d fivon (EF) was related to the extent of dysfunctional but viable myocardium
dex (EDVI).
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Myocardial Viability in Chronic Total Occlusions February 21, 2006:721–5eeks and well-developed collaterals making PCI feasible.
ll patients received a drug-eluting stent with reported low
estenosis/reocclusion rates, and all patients underwent
RI before and after PCI, permitting refined assessment of
eft ventricular volumes and myocardial viability. The mag-
itude of change observed in global left ventricular indexes
as relatively small but in line with previously reported data
n patients studied after myocardial infarction (19,20).
In the present study, ce-MRI predicted 74% of dysfunc-
ional but viable segments correctly for showing improve-
ent in function after revascularization. The remaining
6% of segments did not improve, although 75% of the
all consisted of viable myocardium as defined by ce-MRI.
xperimental studies showed that ce-MRI can accurately
ifferentiate viable myocardium from scarred myocardium
n dogs eight weeks after reperfused infarction (8). How-
ver, viable myocardium in patients with chronic ischemic
eart disease might undergo changes determined by the
everity of the coronary artery stenosis, the duration and
requency of limited flow to the myocardium, and the
uality of myocardial perfusion at rest. Myocardial biopsies
n patients with chronic myocardial ischemia showed signs
f atrophy and degeneration in chronic ischemic but pre-
ominantly viable myocardium (21). These microscopic
hanges of ischemic myocardium are not depicted with
urrently available imaging techniques, but might explain
he variation observed in the reversibility of dysfunctional
ut viable myocardium as defined by ce-MRI. Additional
echniques such as dobutamine stress MRI performed
efore revascularization might identify reversible dys-
unctional myocardium better than ce-MRI because it
llows a direct assessment of the contractile reserve of
ysfunctional myocardium (22). However, a lack of
unctional improvement does not preclude a beneficial
ffect of restoring blood flow to dysfunctional but pre-
ominantly viable myocardium. In the present study,
estoring blood flow to dysfunctional but viable myocar-
ium led to a moderate improvement in function and a
eduction in adverse remodeling in a majority of patients
igure 3. Improvement in segmental wall thickening (SWT) was related to
he transmural extent of infarction assessed with magnetic resonance
maging (MRI) before revascularization. Solid bars  before revascular-
zation; open bars  five months after revascularization.ith a CTO, but other beneficial effects such as preven-ion of arrhythmias and prevention of recurrent myocar-
ial ischemia were not assessed.
tudy limitations. Angiography at follow-up was not per-
ormed, but no clinical evidence of recurrent myocardial
schemia was noted and all patients received a drug-eluting
tent with very low numbers of restenosis reported (4). The
efinition for CTO was arbitrarily set at six weeks in the
resent study, whereas previous studies defined CTO as
even days until three months of occlusion time. Delayed
nhancement patterns at follow-up were not studied, but
ight provide further insight in the pathophysiological
echanisms underlying recovery of function of viable
yocardium.
ONCLUSIONS
mplantation of a drug-eluting stent in patients with a CTO
as a beneficial effect on myocardial contractility and left
entricular volumes. Improvement in regional and global
eft ventricular function after revascularization is related to
he extent of dysfunctional but viable myocardium assessed
ith MRI before revascularization.
eprint requests and correspondence: Dr. Pim J. de Feyter, Eras-
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